col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Wiley: Arthritis & Rheumatology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―02 Brief Report: Humoral and cellular immune responses to SARS-CoV-2 infection and vaccination in B cell depleted autoimmune patients David Simon, Koray Tascilar, Katja Schmidt, Bernhard Manger, Leonie Weckwerth, Maria Sokolova, et al. (+13)
2 [GO] 2021―Jul―02 A case of leukocytoclastic vasculitis after vaccination with a SARS-CoV2-vaccine - a case report Anne Erler, John Fiedler, Anna Koch, Alexander Schütz, Frank Heldmann
3 [GO] 2021―Jun―15 American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2 Jeffrey R. Curtis, Sindhu R. Johnson, Donald D. Anthony, Reuben J. Arasaratnam, Lindsey R. Baden, Anne R. Bass, et al. (+8)
4 [GO] 2021―Jun―11 American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 2 Dawn M. Wahezi, Mindy S. Lo, Tamar B. Rubinstein, Sarah Ringold, Stacy P. Ardoin, Kevin J. Downes, et al. (+7)
5 [GO] 2021―Jun―09 American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3: Comment on the Article by Mikuls et al Jeffrey Hsu, Chin-Hsiu Liu, James C. Wei
6 [GO] 2021―May―27 Commentary on the American College of Rheumatology “COVID-19 Vaccine Clinical Guidance Summary for Patients with Rheumatic and Musculoskeletal Diseases”: use of tofacitinib in the context of COVID-19 vaccination Mahta Mortezavi, Sujatha Menon, Kristen Lee, Jose Rivas
7 [GO] 2021―May―06 Risk of COVID-19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At-Risk Individuals Bryant R. England, Punyasha Roul, Yangyuna Yang, Andre C. Kalil, Kaleb Michaud, Geoffrey M. Thiele, et al. (+3)
8 [GO] 2021―Apr―22 Lupus anticoagulant single positivity at acute phase is not associated with venous thromboembolism or in-hospital mortality in COVID-19 Nicolas Gendron, Marie-Agnès Dragon-Durey, Richard Chocron, Luc Darnige, Georges Jourdi, Aurélien Philippe, et al. (+29)
9 [GO] 2021―Apr―21 Discrimination of COVID-19 from inflammation-induced cytokine storm syndromes by disease-related blood biomarkers Christoph Kessel, Richard Vollenberg, Katja Masjosthusmann, Claas Hinze, Helmut Wittkowski, France Debaugnies, et al. (+9)
10 [GO] 2021―Mar―29 Evidence in the Time of COVID-19 Michael Putman, Sebastian E. Sattui, Jeffrey A. Sparks, Jean W. Liew, Rebecca Grainger, Alí Duarte-García
11 [GO] 2021―Mar―29 Prophylaxis of COVID-19 with Hydroxychloroquine and Chloroquine Wei Tang, Yevgeniya Gartshteyn, Cathy Guo, Tommy Chen, Jon Giles, Anca Askanase
12 [GO] 2021―Mar―22 Risk factors for severe outcomes in patients with systemic vasculitis & COVID-19: a bi-national registry-based cohort study Matthew A Rutherford, Jennifer Scott, Maira Karabayas, Marilina Antonelou, Seerapani Gopaluni, David Gray, et al. (+11)
13 [GO] 2021―Mar―17 American College of Rheumatology Guidance for COVID-19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases - Version 1 Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, Reuben J. Arasaratnam, Lindsey R. Baden, Anne R. Bass, et al. (+8)
14 [GO] 2021―Mar―01 Commentary on “Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series.”: COVID-19 disease in patients with recurrent pericarditis during treatment with anakinra Enrica Negro, Vartan Mardigyan, Lucia Trotta, Massimo Pancrazi, Emanuele Bizzi, Martino Brenna, et al. (+2)
15 [GO] 2021―Jan―29 COVID-19 Reinfection in a Patient Receiving Immunosuppression for ANCA-associated Vasculitis Kavita Gulati, Maria Prendecki, Candice Clarke, Michelle Willicombe, Stephen McAdoo
16 [GO] 2021―Jan―17 Risk factors for COVID-19 and rheumatic disease flare in a US cohort of Latino patients Alice Fike, Julia Hartman, Christopher Redmond, Sandra G. Williams, Yanira Ruiz-Perdomo, Jun Chu, et al. (+4)
17 [GO] 2021―Jan―10 Regulatory action to protect access to hydroxychloroquine for approved rheumatologic indications during COVID-19 in New Zealand Eamon Duffy, Nicola Arroll, Richard Beasley, Thomas Hills
18 [GO] 2020―Dec―31 Antiphospholipid antibodies and thrombosis in patients with COVID-19 T Frapard, S Hue, C Rial, N de Prost, A Mekontso Dessap
19 [GO] 2020―Dec―31 Is the association between IgG anti-cardiolipin autoantibodies and COVID-19 severity related to the lung injury or to the SARS-CoV-2 infection? Daniel Bertin, Alexandre Brodovitch, Abdelouahab Beziane, Xavier Heim, Jean Louis Mege, Nathalie Bardin
20 [GO] 2020―Dec―11 COVID-19 Outcomes in Patients with Systemic Autoimmune Rheumatic Diseases (SARDs) Compared to the General Population: A US Multi-Center Comparative Cohort Study Kristin M. D’Silva, April Jorge, Andrew Cohen, Natalie McCormick, Yuqing Zhang, Zachary S. Wallace, Hyon K. Choi
21 [GO] 2020―Dec―05 American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3 Ted R. Mikuls, Sindhu R. Johnson, Liana Fraenkel, Reuben J. Arasaratnam, Lindsey R. Baden, Bonnie L. Bermas, et al. (+10)
22 [GO] 2020―Dec―05 American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 2. Lauren A. Henderson, Scott W. Canna, Kevin G. Friedman, Mark Gorelik, Sivia K. Lapidus, Hamid Bassiri, et al. (+12)
23 [GO] 2020―Nov―13 Non-steroidal anti-inflammatory drugs and susceptibility to COVID-19 Joht Singh Chandan, Dawit Tefra Zemedikun, Rasiah Thayakaran, Nathan Byne, Samir Dhalla, Dionisio Acosta-Mena, et al. (+18)
24 [GO] 2020―Nov―04 Race/ethnicity association with COVID-19 outcomes in rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance Physician Registry Milena A. Gianfrancesco, Liza A. Leykina, Zara Izadi, Tiffany Taylor, Jeffrey A. Sparks, Carly Harrison, et al. (+57)
25 [GO] 2020―Nov―03 American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Use of Apremilast Pankaj Bansal, Amandeep Goyal, Austin Cusick, Fawad Aslam
26 [GO] 2020―Sep―22 Anakinra for COVID-19: how to interpret elevations in serum liver enzymes Giulio Cavalli, Lorenzo Dagna
27 [GO] 2020―Sep―21 The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm Alice S. Chau, Andrew G. Weber, Naomi I. Maria, Sonali Narain, Audrey Liu, Negin Hajizadeh, et al. (+4)
28 [GO] 2020―Sep―20 Reply - “Anakinra for COVID-19: how to interpret elevations in liver enzymes” Iris Navarro-Millán, Mary K. Crow
29 [GO] 2020―Aug―07 Susceptibility to COVID-19 in patients treated with antimalarials: a population based study in Emilia-Romagna, Northern Italy Carlo Salvarani, Pamela Mancuso, Federica Gradellini, Nilla Viani, Paolo Pandolfi, Massimo Reta, et al. (+12)
30 [GO] 2020―Aug―02 The “Infodemic” of COVID-19 Daniel H. Solomon, Richard Bucala, Mariana J. Kaplan, Peter A. Nigrovic
31 [GO] 2020―Aug―02 Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-analysis Michael Putman, Yu Pei Eugenia Chock, Herman Tam, Alfred H.J. Kim, Sebastian E. Sattui, Francis Berenbaum, et al. (+16)
32 [GO] 2020―Jul―31 American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2 Ted R. Mikuls, Sindhu R. Johnson, Liana Fraenkel, Reuben J. Arasaratnam, Lindsey R. Baden, Bonnie L. Bermas, et al. (+10)
33 [GO] 2020―Jul―31 A Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy Elena Gkrouzman, Medha Barbhaiya, Doruk Erkan, Michael D. Lockshin
34 [GO] 2020―Jul―29 COVID-19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes Rebecca H. Haberman, Rochelle Castillo, Alan Chen, Di Yan, Deborah Ramirez, Vaish Sekar, et al. (+10)
35 [GO] 2020―Jul―29 Synergy between cytokines and risk factors in the cytokine storm of Covid-19: protection from the chronic use of cytokine inhibitors? Pierre Miossec
36 [GO] 2020―Jul―27 Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients with Systemic Lupus Erythematosus Ruth Fernandez-Ruiz, Mala Masson, Mimi Y. Kim, Benjamin Myers, Rebecca H. Haberman, Rochelle Castillo, et al. (+12)
37 [GO] 2020―Jul―24 COVID-19 in Rheumatic Diseases: A Research Agenda Jinoos Yazdany
38 [GO] 2020―Jul―24 American College of Rheumatology Guidance for the Management of Children with Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1 Dawn M. Wahezi, Mindy S. Lo, Tamar B. Rubinstein, Sarah Ringold, Stacy P. Ardoin, Kevin J. Downes, et al. (+7)
39 [GO] 2020―Jul―24 American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 1 Lauren A. Henderson, Scott W. Canna, Kevin G. Friedman, Mark Gorelik, Sivia K. Lapidus, Hamid Bassiri, et al. (+12)
40 [GO] 2020―Jul―07 Covid-19 related IgA vasculitis Matthieu Allez, Blandine Denis, Jean-David Bouaziz, Maxime Battistella, Anne-Marie Zagdanski, Jules Bayart, et al. (+7)
41 [GO] 2020―Jun―30 Brief Report: Anti-phospholipid antibodies in critically ill patients with Coronavirus Disease 2019 (COVID-19) Meng Xiao, Yan Zhang, Shulan Zhang, Xuzhen Qin, Peng Xia, Wei Cao, et al. (+33)
42 [GO] 2020―Jun―30 Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series Iris Navarro-Millán, Sebastian E. Sattui, Amit Lakhanpal, Diane Zisa, Caroline H. Siegel, Mary K. Crow
43 [GO] 2020―Jun―21 Anti-cardiolipin IgG autoantibodies are an independent risk factor of COVID-19 severity Daniel Bertin, Alexandre Brodovitch, Abdou Beziane, Sylvia Hug, Afaf Bouamri, Jean Louis Mege, Nathalie Bardin
44 [GO] 2020―Jun―17 Children's (and autoimmune patients) morbidity (and mortality) from Covid-19 is similar to the general population: immunologic rationale. Edoardo Sean Ferraccioli, Elisa Gremese, Gianfranco Ferraccioli
45 [GO] 2020―Jun―17 Impact of home confinement during the COVID-19 pandemic on medication use and disease activity in spondyloarthritis patients CH Roux, O Brocq, F Gerald, C Pradier, L Bailly
46 [GO] 2020―Jun―07 Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? Ennio Giulio Favalli, Sara Monti, Francesca Ingegnoli, Silvia Balduzzi, Roberto Caporali, Carlomaurizio Montecucco
47 [GO] 2020―May―27 Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab Benedict Fallet, Diego Kyburz, Ulrich A. Walker
48 [GO] 2020―May―07 Widening Disparities Among Patients with Rheumatic Diseases in the COVID-19 Era: An Urgent Call to Action Candace H. Feldman, Rosalind Ramsey-Goldman
49 [GO] 2020―Apr―29 American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic Ted R. Mikuls, Sindhu R Johnson, Liana Fraenkel, Reuben J. Arasaratnam, Lindsey R. Baden, Bonnie L. Bermas, et al. (+10)
50 [GO] 2020―Apr―15 On the alert for cytokine storm: Immunopathology in COVID-19 Lauren A. Henderson, Scott W. Canna, Grant S. Schulert, Stefano Volpi, Pui Y. Lee, Kate F. Kernan, et al. (+13)
51 [GO] 2020―Apr―09 Stand Together and Deliver: Challenges and Opportunities for Rheumatology Education During the COVID19 Pandemic Fotios Koumpouras, Simon Helfgott


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.009 sec